TY - JOUR T1 - Persistence of airway inflammation in smokers who switch to electronic cigarettes JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00117-2022 VL - 8 IS - 2 SP - 00117-2022 AU - Michael D. Kim AU - Nathalie Baumlin AU - Andrea Guerrero-Cignarella AU - Andreas Schmid AU - Carolina Aguiar AU - Mohiuddin Mohiuddin AU - John S. Dennis AU - Jasjit S. Ahluwalia AU - Eleanor L. Leavens AU - Nikki Nollen AU - Michael Campos AU - Matthias Salathe Y1 - 2022/04/01 UR - http://openres.ersjournals.com/content/8/2/00117-2022.abstract N2 - Despite increased awareness of the potential risks of electronic cigarette (e-cigarette) use [1], vaping e-liquids containing nicotine continues to be thought of as a less harmful alternative to smoking combustible cigarettes. Recent evidence points to nicotine-containing e-cigarettes, either alone or in combination with nicotine patches, as being effective for smoking cessation [2, 3]. Although both e-cigarettes and nicotine replacement therapy (NRT) provide a replacement source of nicotine, e-cigarettes are often vaped over the long term while NRT is applied mostly for a discrete quitting period [2].As opposed to smoking cessation with nicotine-replacement therapy and/or varenicline, nicotine-containing e-cigarette use does not improve some airway inflammatory markers. https://bit.ly/3FyqIt9We would like to thank Tricia Snow, Michael Arnold and Terri Tapp for their help monitoring abstinence and collecting nasal samples from study participants at Swope Health. ER -